Complete alcohol abstinence increases the risk of NAFLD but not severity. A population analysis with transient elastography

Refrences

• Neuschwander-Tetri BA. Non-alcoholic fatty liver disease. BMC Med. 2017;15(1):45.
   PubMed Web of Science ®Google Scholar
• Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313(22):2263–2273.
   PubMed Web of Science ®Google Scholar
• Muthiah MD, Cheng Han N, Sanyal AJ. A clinical overview of non-alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications—what the non-specialist needs to know. Diabetes Obes Metab. 2022;24(S2):3–14.
   PubMedGoogle Scholar
• Bedossa P. Pathology of non-alcoholic fatty liver disease. Liver Int. 2017;37(S1):85–89.
   PubMedGoogle Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328–357.
   PubMed Web of Science ®Google Scholar
• Lucey MR, Im GY, Mellinger JL, et al. Introducing the 2019 American association for the study of liver diseases guidance on alcohol-associated liver disease. Liver Transpl. 2020;26(1):14–16.
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Brunt EM, Kleiner DE, et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011;54(1):344–353.
   PubMedGoogle Scholar
• Ajmera VH, Terrault NA, Harrison SA. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review. Hepatology. 2017;65(6):2090–2099.
   PubMed Web of Science ®Google Scholar
• Reynolds K, Lewis B, Nolen JD, et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289(5):579–588.
   PubMed Web of Science ®Google Scholar
• Ronksley PE, Brien SE, Turner BJ, et al. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.
   PubMed Web of Science ®Google Scholar
• Kodama S, Saito K, Tanaka S, et al. Alcohol consumption and risk of atrial fibrillation: a meta-analysis. J Am Coll Cardiol. 2011;57(4):427–436.
   PubMed Web of Science ®Google Scholar
• Hajifathalian K, Torabi Sagvand B, McCullough AJ. Effect of alcohol consumption on survival in nonalcoholic fatty liver disease: a national prospective cohort study. Hepatology. 2019;70(2):511–521.
   PubMed Web of Science ®Google Scholar
• Wongtrakul W, Niltwat S, Charatcharoenwitthaya P. The effects of modest alcohol consumption on non-alcoholic fatty liver disease: a systematic review and meta-analysis. Front Med (Lausanne). 2021;8:744713.
   PubMed Web of Science ®Google Scholar
• Toh JZK, Pan XH, Tay PWL, et al. A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2021;22;S1542-3565(21)01035-1.
   Google Scholar
• Tang ASP, Chan KE, Quek J, et al. NAFLD increases risk of carotid atherosclerosis and ischemic stroke. An updated meta-analysis with 135,602 individuals. Clin Mol Hepatol. 2022;28(3):483–496.
   PubMed Web of Science ®Google Scholar
• Yong JN, Lee CWM, Chan YY, et al. A meta-analysis of 33,891 patients on the association between non-alcoholic fatty liver disease and diastolic. Systolic and Struct Heart Dysfunct Hepatol Int. 2022;16(2):269–281.
   Google Scholar
• CDC. National Health and Nutrition Examination Survey (NHANES). 2017.
   Google Scholar
• National Health and Nutrition Examination Survey (NHANES). MEC Laboratory Procedures Manual. Centers for disease control and prevention. 2017.
   Google Scholar
• Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66(5):1022–1030.
   PubMed Web of Science ®Google Scholar
• Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55(3):403–408.
   PubMed Web of Science ®Google Scholar
• Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet Jan. 2004;363(9403):157–163.
   PubMed Web of Science ®Google Scholar
• Blackwell M, Iacus S, King G, et al. CEM: Coarsened exact matching in stata. The Stata J. 2009;9(4):524–546.
   Web of Science ®Google Scholar
• Petroni ML, Brodosi L, Marchignoli F, et al. Moderate alcohol intake in non-alcoholic fatty liver disease: to drink or not to drink? Nutrients. 2019;11(12):3048.
   PubMed Web of Science ®Google Scholar
• Gunji T, Sato H, Iijima K, et al. Modest alcohol consumption has an inverse association with liver fat content. HGE. 2012;59(120):2552–2556.
   Google Scholar
• Hiramine Y, Imamura Y, Uto H, et al. Alcohol drinking patterns and the risk of fatty liver in Japanese men. J Gastroenterol. 2011;46(4):519–528.
   PubMed Web of Science ®Google Scholar
• Joosten MM, Beulens JW, Kersten S, et al. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia. 2008;51(8):1375–1381.
   PubMed Web of Science ®Google Scholar
• Bonnet F, Disse E, Laville M, et al. Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women. Diabetologia. 2012;55(12):3228–3237.
   PubMed Web of Science ®Google Scholar
• Davies MJ, Baer DJ, Judd JT, et al. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287(19):2559–2562.
   PubMed Web of Science ®Google Scholar
• Kanuri G, Landmann M, Priebs J, et al. Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice. Eur J Nutr. 2016;55(3):1153–1164.
   PubMed Web of Science ®Google Scholar
• Parthasarathy G, Revelo X, Malhi H. Pathogenesis of nonalcoholic steatohepatitis: an overview. Hepatol Commun. 2020;4(4):478–492.
   PubMed Web of Science ®Google Scholar
• Ajmera V, Belt P, Wilson LA, et al. Among patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis. Clin Gastroenterol Hepatol. 2018;16(9):1511–1520.e5.
   PubMed Web of Science ®Google Scholar
• Ekstedt M, Franzén LE, Holmqvist M, et al. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scand J Gastroenterol. 2009;44(3):366–374.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu Y, Li S, et al. Alcohol consumption and risk of cardiovascular disease, cancer and mortality: a prospective cohort study. Nutr J. 2021;20(1):13.
   PubMed Web of Science ®Google Scholar
• Sacco RL, Elkind M, Boden-Albala B, et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA. 1999;281(1):53–60.
   PubMed Web of Science ®Google Scholar
• Hines LM, Rimm EB. Moderate alcohol consumption and coronary heart disease: a review. Postgrad Med J. 2001;77(914):747–752.
   PubMed Web of Science ®Google Scholar
• Xi B, Veeranki SP, Zhao M, et al. Relationship of alcohol consumption to all-cause, cardiovascular, and cancer-related mortality in U.S. Adults. J Am Coll Cardiol. 2017;70(8):913–922.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhong G-C, Tan H-Y, et al. Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis. Sci Rep. 2019;9(1):11124.
   PubMed Web of Science ®Google Scholar
• Turati F, Galeone C, Rota M, et al. Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies. Ann Oncol. /2014;25(8):1526–1535.
   PubMed Web of Science ®Google Scholar
• Chuang SC, Lee YC, Wu GJ, et al. Alcohol consumption and liver cancer risk: a Meta-analysis. Cancer Causes Control. 2015;26(9):1205–1231.
   PubMed Web of Science ®Google Scholar
• Griswold MG, Fullman N, Hawley C, et al. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. The Lancet. 2018;392(10152):1015–1035.
   PubMed Web of Science ®Google Scholar
• Grant BF, Chou SP, Saha TD, et al. Prevalence of 12-Month alcohol use, High-Risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: Results from the national epidemiologic survey on alcohol and related conditions. JAMA Psychiatry. 2017;74(9):911–923.
   PubMed Web of Science ®Google Scholar
• Leasure JL, Neighbors C, Henderson CE, et al. Exercise and alcohol consumption: what we know, what we need to know, and why it is important. Review. Front Psychiatry. 2015;6:156.
   PubMed Web of Science ®Google Scholar
• Werneck AO, Oyeyemi AL, Szwarcwald CL, et al. Association between physical activity and alcohol consumption: sociodemographic and behavioral patterns in Brazilian adults. J Pub Health (Oxf). 2019;41(4):781–787.
   PubMed Web of Science ®Google Scholar